XNAS:CERN Cerner Corp Quarterly Report 10-Q Filing - 3/31/2012

Effective Date 3/31/2012

XNAS:CERN (Cerner Corp): Fair Value Estimate
Premium
XNAS:CERN (Cerner Corp): Consider Buying
Premium
XNAS:CERN (Cerner Corp): Consider Selling
Premium
XNAS:CERN (Cerner Corp): Fair Value Uncertainty
Premium
XNAS:CERN (Cerner Corp): Economic Moat
Premium
XNAS:CERN (Cerner Corp): Stewardship
Premium
 
Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

 

(X)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended         March 31, 2012         

OR

 

(  )

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                          to                             

Commission File Number         0-15386            

                CERNER CORPORATION                

(Exact name of registrant as specified in its charter)

 

Delaware   43-1196944

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer Identification

Number)

2800 Rockcreek Parkway

North Kansas City, Missouri 64117

                                         (816) 201-1024                                         

(Address of Principal Executive Offices, including zip code;

registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X]     No [  ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes [X]     No [  ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [X]     Accelerated filer [  ]     Non-accelerated filer [  ]     Smaller reporting company [  ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [  ]       No [X]

Indicate the number of shares outstanding of the issuer’s classes of common stock, as of the latest practicable date.

 

Class

  

Outstanding at April 19, 2012

Common Stock, $0.01 par value per share    170,456,705 shares


Table of Contents

CERNER CORPORATION AND SUBSIDIARIES

I N D E X

 

Part I.    Financial Information:   
Item 1.    Financial Statements:   
   Condensed Consolidated Balance Sheets as of March 31, 2012
(unaudited) and December 31, 2011
   1
   Condensed Consolidated Statements of Operations for the three
months ended March 31, 2012 and April 2, 2011 (unaudited)
   2
   Condensed Consolidated Statements of Comprehensive Income
for the three months ended March 31, 2012 and April 2, 2011 (unaudited)
   3
   Condensed Consolidated Statements of Cash Flows for the three
months ended March 31, 2012 and April 2, 2011 (unaudited)
   4
   Notes to Condensed Consolidated Financial Statements (unaudited)    5
Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations    11
Item 3.    Quantitative and Qualitative Disclosures about Market Risk    19
Item 4.    Controls and Procedures    19
Part II.    Other Information:    20
Item 6.    Exhibits    20


Table of Contents

CERNER CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

As of March 31, 2012 (unaudited) and December 31, 2011

 

00$0,000,0000 00$0,000,0000
  

 

 

 

(In thousands, except share data)

   2012      2011  
  

 

 

 

Assets

     

Current assets:

     

Cash and cash equivalents

       $ 281,198        $ 243,146     

Short-term investments

     612,644          531,635     

Receivables, net

     535,504          563,209     

Inventory

     14,141          23,296     

Prepaid expenses and other

     100,564          94,232     

Deferred income taxes, net

     47,420          46,795     
  

 

 

 

Total current assets

     1,591,471          1,502,313     

Property and equipment, net

     495,918          488,996     

Software development costs, net

     252,588          248,750     

Goodwill

     213,006          211,826     

Intangible assets, net

     71,959          75,366     

Long-term investments

     375,039          359,324     

Other assets

     139,578          113,783     
  

 

 

 

Total assets

       $ 3,139,559        $ 3,000,358     
  

 

 

 

Liabilities and Shareholders’ Equity

     

Current liabilities:

     

Accounts payable

       $ 113,568        $ 85,545     

Current installments of long-term debt

     44,778          39,722     

Deferred revenue

     164,846          153,139     

Accrued payroll and tax withholdings

     92,365          109,227     

Other accrued expenses

     27,963          51,087     
  

 

 

 

Total current liabilities

     443,520          438,720     

Long-term debt and other obligations

     107,856          86,821     

Deferred income taxes and other liabilities

     132,192          150,229     

Deferred revenue

     12,139          13,787     
  

 

 

 

Total liabilities

     695,707          689,557     
  

 

 

 

Shareholders’ Equity:

     

Cerner Corporation shareholders’ equity:

     

Common stock, $.01 par value, 250,000,000 shares authorized, 170,434,135 shares issued at March 31, 2012 and 169,565,856 shares issued at December 31, 2011

     1,704          1,696     

Additional paid-in capital

     759,857          723,490     

Retained earnings

     1,686,170          1,597,462     

Accumulated other comprehensive loss, net

     (3,999)         (11,967)    
  

 

 

 

Total Cerner Corporation shareholders’ equity

     2,443,732          2,310,681     

Noncontrolling interest

     120          120     
  

 

 

 

Total shareholders’ equity

     2,443,852          2,310,801     
  

 

 

 

Total liabilities and shareholders’ equity

       $         3,139,559        $         3,000,358     
  

 

 

 

See notes to condensed consolidated financial statements (unaudited).

 

1


Table of Contents

CERNER CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

For the three months ended March 31, 2012 and April 2, 2011

(unaudited)

 

     Three Months Ended  

(In thousands, except per share data)

               2012                         2011              
  

 

 

 

Revenues:

    

System sales

       $ 225,820       $ 140,379     

Support, maintenance and services

     403,904         340,994     

Reimbursed travel

     11,488         10,291     
  

 

 

 

Total revenues

     641,212         491,664     
  

 

 

 

Costs and expenses:

    

Cost of system sales

     116,955         58,099     

Cost of support, maintenance and services

     29,565         22,290     

Cost of reimbursed travel

     11,488         10,291     

Sales and client service

     245,074         201,348     

Software development

    (Includes amortization of $19,389 and $19,058, respectively)

     71,145         71,144     

General and administrative

     39,546         34,793     
  

 

 

 

Total costs and expenses

     513,773         397,965     
  

 

 

 

Operating earnings

     127,439         93,699     

Other income:

    

Interest income, net

     2,619         1,976     

Other income

            35     
  

 

 

 

Total other income, net

     2,624         2,011     
  

 

 

 

Earnings before income taxes

     130,063         95,710     

Income taxes

     (41,355)        (31,154)    
  

 

 

 

Net earnings

       $ 88,708       $ 64,556     
  

 

 

 

Basic earnings per share

       $ 0.52       $ 0.38     

Diluted earnings per share

       $ 0.51       $ 0.37     

Basic weighted average shares outstanding

     169,968         167,110     

Diluted weighted average shares outstanding

     175,027         172,653     

See notes to condensed consolidated financial statements (unaudited).

 

2


Table of Contents

CERNER CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

For the three months ended March 31, 2012 and April 2, 2011

(unaudited)

 

     Three Months Ended  

(In thousands)

               2012                             2011              
  

 

 

 

Net earnings

       $ 88,708      $ 64,556     

Foreign currency translation adjustments and other (net of
tax of $731 and $898, respectively)

     7,968        11,691     
  

 

 

 

Comprehensive income

       $ 96,676      $ 76,247     
  

 

 

 

See notes to condensed consolidated financial statements (unaudited).

 

3


Table of Contents

CERNER CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

For the three months ended March 31, 2012 and April 2, 2011

(unaudited)

 

     Three Months Ended  

(In thousands)

               2012                             2011              
  

 

 

 

CASH FLOWS FROM OPERATING ACTIVITIES:

    

Net earnings

       $ 88,708       $ 64,556     

Adjustments to reconcile net earnings to net cash provided by
operating activities:

    

Depreciation and amortization

     52,789         50,140     

Share-based compensation expense

     8,331         6,944     

Provision for deferred income taxes

     (5,310)        5,999     

Changes in assets and liabilities:

    

Receivables, net

     6,979         6,918     

Inventory

     9,263         (2,609)    

Prepaid expenses and other

     (823)        (13,449)    

Accounts payable

     20,487         -     

Accrued income taxes

     (30,189)        2,509     

Deferred revenue

     9,762         11,050     

Other accrued liabilities

     2,711         (5,557)    
  

 

 

 

Net cash provided by operating activities

     162,708         126,501     
  

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

    

Capital purchases

     (26,363)        (21,372)    

Capitalized software development costs

     (23,080)        (20,466)    

Purchases of investments

     (365,733)        (348,566)    

Maturities of investments

     265,632         203,367     

Purchase of other intangibles

     (2,899)        (3,228)    
  

 

 

 

Net cash used in investing activities

     (152,443)        (190,265)    
  

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

    

Repayment of long-term debt

     (970)        (114)    

Proceeds from excess tax benefits from stock
compensation

     16,299         15,698     

Proceeds from exercise of options

     10,982         16,341     

Contingent consideration payments for acquisition of
business

            (780)    
  

 

 

 

Net cash provided by financing activities

     26,311         31,145     
  

 

 

 

Effect of exchange rate changes on cash and cash equivalents

     1,476         2,675     
  

 

 

 

Net increase (decrease) in cash and cash equivalents

     38,052         (29,944)    

Cash and cash equivalents at beginning of period

     243,146         214,511     
  

 

 

 

Cash and cash equivalents at end of period

       $ 281,198       $ 184,567     
  

 

 

 

See notes to condensed consolidated financial statements (unaudited).

 

4


Table of Contents

CERNER CORPORATION AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

(1)

Interim Statement Presentation

The condensed consolidated financial statements included herein have been prepared by Cerner Corporation (the Company) without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in our latest annual report on Form 10-K.

In management’s opinion, the accompanying unaudited condensed consolidated financial statements include all adjustments (consisting of only normal recurring adjustments) necessary to present fairly the financial position and the results of operations and cash flows for the periods presented. Our interim results as presented in this Form 10-Q are not necessarily indicative of the operating results for the entire year.

The condensed consolidated financial statements were prepared using GAAP. These principles require us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results could differ from those estimates.

Our first fiscal quarter ends on the Saturday closest to March 31. The 2012 and 2011 first quarters ended on March 31, 2012 and April 2, 2011, respectively. All references to years in these notes to condensed consolidated financial statements represent the respective three months ended on such dates, unless otherwise noted.

On May 27, 2011, the Board of Directors of the Company approved a two-for-one split of our common stock in the form of a one hundred percent (100%) stock dividend, which was distributed on June 24, 2011 to shareholders of record as of June 15, 2011. All share and per share data have been retroactively adjusted for all periods presented to reflect the stock split, as if the stock split had occurred at the beginning of the earliest period presented.

Recently Adopted Accounting Pronouncements

Comprehensive Income. On January 1, 2012, we adopted Financial Accounting Standards Board (FASB) Accounting Standards Update (ASU) 2011-05, Presentation of Comprehensive Income. ASU 2011-05 requires an entity to present the total of comprehensive income, the components of net income, and the components of other comprehensive income either in a single continuous statement of comprehensive income or in two separate but consecutive statements. ASU 2011-05 eliminates the option to present the components of other comprehensive income as part of the statement of changes in equity. These condensed consolidated financial statements include separate Condensed Consolidated Statements of Comprehensive Income.

Goodwill Impairment. On January 1, 2012, we adopted FASB ASU 2011-08, Testing for Goodwill Impairment. ASU 2011-08 amends existing guidance by giving an entity the option to first assess qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than the carrying amount. The more-likely-than-not threshold is defined as having a likelihood of more than 50 percent. If an entity determines that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then it is necessary to perform the two-step goodwill impairment test, as currently prescribed by ASC Topic 350. Otherwise, the two-step goodwill impairment test is not required. The adoption of this standard did not have a material effect on our condensed consolidated financial statements.

 

(2)

Fair Value Measurements

We determine fair value measurements used in our condensed consolidated financial statements based upon the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity’s own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable

 

5


Table of Contents

inputs). The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy are described below:

 

 

 

Level 1 – Valuations based on quoted prices in active markets for identical assets or liabilities that the entity has the ability to access.

 

 

 

Level 2 – Valuations based on quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities.

 

 

 

Level 3 – Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

The following table details our financial assets measured at fair value within the fair value hierarchy:

 

(In thousands)

        March 31, 2012      December 31, 2011  
    

Balance Sheet

   Fair Value Measurements Using      Fair Value Measurements Using  

Description

  

Classification

   Level 1      Level 2      Level 3      Level 1      Level 2      Level 3  

Money market funds

  

Cash equivalents

   $ 58,113       $ -         $ -         $ 123,919       $ -         $ -     

Time deposits

  

Cash equivalents

     -           8,331         -           -           7,358         -     

Corporate bonds

  

Cash equivalents

     -           1,775         -           -           -           -     

Time deposits

  

Short-term investments

     -           80,302         -           -           67,632         -     

Commercial paper

  

Short-term investments

     -           48,250         -           -           23,250         -     

Government and corporate bonds

  

Short-term investments

     -           484,092         -           -           440,753         -     

Time deposits

  

Long-term investments

     -           -           -           -           19,579         -     

Government and corporate bonds

  

Long-term investments

     -           369,039         -           -           337,245         -     

We estimate the fair value of our long-term, fixed rate debt using a Level 3 discounted cash flow analysis based on current borrowing rates for debt with similar maturities. The fair value of our long-term debt, including current maturities, at March 31, 2012 and December 31, 2011 was approximately $75.7 million and $72.6 million, respectively. The carrying amount of such fixed-rate debt at March 31, 2012 and December 31, 2011 was $69.2 million and $67.5 million, respectively.

 

(3)

Receivables

A summary of net receivables is as follows:

 

         March 31, 2012     December 31, 2011  
  

 

 

 

(In thousands)

            

Gross accounts receivable

       $ 476,422          $ 496,706     

Less: Allowance for doubtful accounts

     26,321        24,270     
  

 

 

 

Accounts receivable, net of allowance

     450,101        472,436     

Contracts receivable

     74,507        81,776     

Current portion of lease receivables

     10,896        8,997     
  

 

 

 

Total receivables, net

       $ 535,504          $ 563,209     
  

 

 

 

During the second quarter of 2008, Fujitsu Services Limited’s (Fujitsu) contract as the prime contractor in the National Health Service (NHS) initiative to automate clinical processes and digitize medical records in the Southern region of England was terminated by the NHS. This had the effect of automatically terminating our subcontract for the project. We are in dispute with Fujitsu regarding Fujitsu’s obligation to pay the amounts comprised of accounts receivable and contracts receivable related to that subcontract, and we are working with Fujitsu to resolve these issues based on processes provided for in the contract. Part of that process requires resolution of disputes between Fujitsu and the NHS regarding the contract termination. As of March 31, 2012, it remains unlikely that the matter will be resolved in the next 12 months. Therefore these receivables have been classified as long-term and represent less than the majority of other long-term assets as of the quarter ended March 31, 2012. While the ultimate collectability of the receivables pursuant to this process is uncertain, we believe that we have valid and equitable grounds for recovery of such amounts and that collection of recorded amounts is probable.

 

6


Table of Contents

During the first three months of 2012 and 2011, we received total client cash collections of $683.2 million and $531.1 million, respectively, of which $16.7 million and $16.0 million were received from third party arrangements with non-recourse payment assignments.

 

(4)

Income Taxes

We determine the tax provision for interim periods using an estimate of our annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter we update our estimate of the annual effective tax rate, and if our estimated tax rate changes, we make a cumulative adjustment. We classify interest and penalties associated with unrecognized tax benefits as income tax expense in our Condensed Consolidated Statements of Operations.

Our effective tax rate was 31.8% and 32.6% for the first three months of 2012 and 2011, respectively. This decrease was primarily due to an increase in net favorable discrete items recorded in 2012 relative to 2011, partially offset by the expiration of the research and development tax credit on December 31, 2011.

We recorded an adjustment to our unrecognized tax benefits during the first quarter of 2012, resulting from the settlement of an ongoing tax audit, which favorably impacted our income tax provision by $12.0 million. We do not anticipate recognition of any material unrecognized tax benefits in the next twelve months. In the first quarter of 2012, we also recognized $5.6 million of tax expense as a discrete item in connection with the license of certain intellectual property rights to a wholly owned foreign subsidiary.

 

(5)

Earnings Per Share

A reconciliation of the numerators and the denominators of the basic and diluted per share computations are as follows:

 

    Three Months Ended  
    2012     2011  
        Earnings     Shares     Per-Share     Earnings     Shares     Per-Share  

(In thousands, except per share data)

      (Numerator)     (Denominator)     Amount     (Numerator)     (Denominator)     Amount  
 

 

 

   

 

 

 

Basic earnings per share:

           

Income available to
common shareholders

    $ 88,708        169,968       $ 0.52      $         64,556        167,110       $ 0.38   

Effect of dilutive securities:

           

Stock options and non-vested shares

    -        5,059           -        5,543      
 

 

 

     

 

 

   

Diluted earnings per share:

           

Income available to common
shareholders including
assumed conversions

    $ 88,708        175,027       $ 0.51      $       64,556        172,653       $ 0.37   
 

 

 

     

 

 

   

Options to purchase 1.5 million and 1.6 million shares of common stock at per share prices ranging from $49.06 to $76.86 and $38.06 to $53.01 were outstanding at March 31, 2012 and April 2, 2011, respectively, but were not included in the computation of diluted earnings per share because the options were anti-dilutive.

 

7


Table of Contents

(6)

Share-Based Compensation

Stock Options

Options activity for the three months ended March 31, 2012 was as follows:

 

(In thousands, except per share data)

   For the Three Months Ended March 31, 2012

Options

  

Number of

Shares

   

Weighted-

Average

Exercise Price

   

Aggregate

Intrinsic Value

   

Weighted-Average      

Remaining      

Contractual Term      

 

Outstanding at beginning of year

     12,909        $ 23.78       

Granted

     290          76.58       

Exercised

     (840)         13.66       

Forfeited and expired

     (55)         35.51       
  

 

 

       

Outstanding as of March 31, 2012

     12,304        $ 25.67      $ 621,466      6.24
  

 

 

       

Exercisable as of March 31, 2012

     7,884        $ 15.59      $ 477,489      5.24

We valued options granted in 2012 under the Cerner Corporation 2011 Omnibus Equity Incentive Plan using the following weighted average assumptions:

 

Expected volatility (%)

     34.2   

Expected term (yrs)

     9.2   

Risk-free rate (%)

     2.2   

Fair value per option

   $         34.90   

As of March 31, 2012, there was $70.4 million of total unrecognized compensation cost related to stock options granted under all plans. That cost is expected to be recognized over a weighted-average period of 3.01 years.

Non-vested Shares

Non-vested share activity for the three months ended March 31, 2012 was as follows:

 

(In thousands, except per share data)

   For the Three Months Ended March 31, 2012  

Restricted Stock

   Number of Shares    

Weighted-Average

Grant Date Fair

Value

 

 

 

Outstanding at beginning of year

     254        $ 47.75   

Granted

     37          76.63   

Vested

     -            -     

Forfeited

     -            -     
  

 

 

   

Outstanding as of March 31, 2012

     291        $ 51.43   
  

 

 

   

As of March 31, 2012, there was $8.5 million of total unrecognized compensation cost related to non-vested share awards granted under all plans. That cost is expected to be recognized over a weighted-average period of 1.55 years.

 

8


Table of Contents

The following table presents the total compensation expense recognized in the condensed consolidated statements of operations with respect to stock options, non-vested shares and our Associate Stock Purchase Plan:

 

     Three Months Ended  

(In thousands)

           2012                     2011          
  

 

 

 

Stock option and non-vested share compensation expense

       $ 8,331       $ 6,944     

Associate stock purchase plan expense

     732         482     

Amounts capitalized in software development costs, net of amortization

     (114)        (65)    
  

 

 

 

Amounts charged against earnings, before income tax benefit

       $ 8,949       $ 7,361     
  

 

 

 

Amount of related income tax benefit recognized in earnings

       $ 3,423       $ 2,805     
  

 

 

 

 

(7)

Hedging Activities

The following table represents the fair value of our net investment hedge included within the Condensed Consolidated Balance Sheets and the related unrealized gain or loss, net of related income tax effects, on the net investment hedge recognized in comprehensive income:

 

(In thousands)

             Net Unrealized Gain (Loss)  
     Balance Sheet   Fair Value     For the Three Months Ended    
    

 

 

 

Derivatives Designated

   Classification   March 31, 2012     December 31, 2011     2012     2011  

 

 

Net investment hedge

   Short-term liabilities       $ 14,867      $ 14,421      $ (276   $ 292     

Net investment hedge

   Long-term liabilities     44,602        43,262        (827     1,168     
    

 

 

 

Total net investment hedge

      $ 59,469      $ 57,683      $ (1,103   $ 1,460     
    

 

 

 

 

(8)

Contingencies

The terms of our software license agreements with our clients generally provide for a limited indemnification of such clients against losses, expenses and liabilities arising from third party claims based on alleged infringement by our solutions of an intellectual property right of such third party. The terms of such indemnification often limit the scope of and remedies for such indemnification obligations and generally include a right to replace or modify an infringing solution. To date, we have not had to reimburse any of our clients for any losses related to these indemnification provisions pertaining to third party intellectual property infringement claims. For several reasons, including the lack of prior indemnification claims and the lack of a monetary liability limit for certain infringement cases under the terms of the corresponding agreements with our clients, we cannot determine the maximum amount of potential future payments, if any, related to such indemnification provisions.

 

(9)

Segment Reporting

We have two operating segments, Domestic and Global. Revenues are derived primarily from the sale of clinical, financial and administrative information systems and solutions. The cost of revenues includes the cost of third party consulting services, computer hardware, devices and sublicensed software purchased from manufacturers for delivery to clients. It also includes the cost of hardware maintenance and sublicensed software support subcontracted to the manufacturers. Operating expenses incurred by the geographic business segments consist of sales and client service expenses including salaries of sales and client service personnel, communications expenses and unreimbursed travel expenses. Performance of the segments is assessed at the operating earnings level and, therefore, the segment operations have been presented as such. “Other” includes revenues not generated by the operating segments and expenses that have not been allocated to the operating segments, such as software development, marketing, general and administrative, share-based compensation expense and depreciation. We manage our operating segments to the operating earnings level. Items such as interest, income taxes, capital expenditures and total assets are managed at the consolidated level and thus are not included in our operating segment disclosures.

 

9


Table of Contents

Accounting policies for each of the reportable segments are the same as those used on a consolidated basis. The following table presents a summary of the operating information for the three months ended March 31, 2012 and April 2, 2011:

 

000,000,000 000,000,000 000,000,000 000,000,000
     Operating Segments  

(In thousands)

   Domestic          Global             Other                 Total      

Three months ended 2012

        

Revenues

    $ 554,274         $ 86,938         $ -         $ 641,212     
  

 

 

   

 

 

   

 

 

   

 

 

 

Cost of revenues

     134,303          23,705          -          158,008     

Operating expenses

     120,438          32,751          202,576          355,765     
  

 

 

   

 

 

   

 

 

   

 

 

 

Total costs and
expenses

     254,741          56,456          202,576          513,773     
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating earnings (loss)

    $ 299,533         $ 30,482         $ (202,576)        $ 127,439     
  

 

 

   

 

 

   

 

 

   

 

 

 
     Operating Segments  

(In thousands)

       Domestic                     Global                     Other                     Total          

Three months ended 2011

        

Revenues

    $ 420,990         $ 70,674         $ -         $ 491,664     
  

 

 

   

 

 

   

 

 

   

 

 

 

Cost of revenues

     77,925          12,755          -          90,680     

Operating expenses

     105,349          29,099          172,837          307,285     
  

 

 

   

 

 

   

 

 

   

 

 

 

Total costs and
expenses

     183,274          41,854          172,837          397,965     
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating earnings (loss)

    $ 237,716         $ 28,820         $ (172,837)        $ 93,699     
  

 

 

   

 

 

   

 

 

   

 

 

 

 

10


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following Management Discussion and Analysis (MD&A) is intended to help the reader understand the results of operations and financial condition of Cerner Corporation (Cerner, the Company, we, us or our). This MD&A is provided as a supplement to, and should be read in conjunction with, our condensed consolidated financial statements and the accompanying notes to the financial statements (Notes) found above.

Our first fiscal quarter ends on the Saturday closest to March 31. The 2012 and 2011 first quarters ended on March 31, 2012 and April 2, 2011, respectively. All references to years in this MD&A represent the respective three months ended on such dates, unless otherwise noted.

Except for the historical information and discussions contained herein, statements contained in this quarterly report on Form 10-Q may constitute “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended (the Exchange Act). Forward-looking statements can often be identified by the use of forward-looking terminology, such as "could," "should," “will,” "intended," "continue," "believe," "may," "expect," "hope," "anticipate," "goal," "forecast," “plan,” “guidance” or “estimate” or the negative of these words, variations thereof or similar expressions. These statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially, including: the possibility of product-related liabilities; potential claims for system errors and warranties; the possibility of interruption at our data centers or client support facilities; our proprietary technology may be subject to claims for infringement or misappropriation of intellectual property rights of others, or may be infringed or misappropriated by others; risks associated with our non-U.S. operations; risks associated with our ability to effectively hedge exposure to fluctuations in foreign currency exchange rates; the potential for tax legislation initiatives that could adversely affect our tax position and/or challenges to our tax positions in the United States and non-U.S. countries; risks associated with our recruitment and retention of key personnel; risks related to our reliance on third party suppliers; risks inherent with business acquisitions; the potential for losses resulting from asset impairment charges; risks associated with the ongoing adverse financial market environment and uncertainty in global economic conditions; changing political, economic, regulatory and judicial influences; government regulation; significant competition and market changes; variations in our quarterly operating results; potential inconsistencies in our sales forecasts compared to actual sales; volatility in the trading price of our common stock and the timing and volume of market activity; the authority of our Board of Directors to issue preferred stock and anti-takeover provisions contained in our corporate governance documents; material adverse resolution of legal proceedings; and, other risks, uncertainties and factors discussed elsewhere in this Form 10-Q, in our other filings with the Securities and Exchange Commission or in materials incorporated therein by reference. Forward looking statements are not guarantees of future performance or results. The reader should not place undue reliance on forward-looking statements since the statements speak only as to the date they are made. We undertake no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial condition or business over time.

Management Overview

Our revenues are primarily derived by selling, implementing and supporting software solutions, clinical content, hardware, health care devices and services that give health care providers secure access to clinical, administrative and financial data in real time, allowing them to improve the quality, safety and efficiency in the delivery of health care.

Our fundamental strategy centers on creating organic growth by investing in research and development (R&D) to create solutions and services for the health care industry. This strategy has driven strong growth over the long-term, as reflected in five- and ten-year compound annual revenue growth rates of 10% or more. This growth has also created an important strategic footprint in health care, with Cerner® solutions licensed by approximately 9,300 facilities around the world, including more than 2,650 hospitals; 3,750 physician practices; 40,000 physicians; 500 ambulatory facilities, such as laboratories, ambulatory centers, cardiac facilities, radiology clinics and surgery centers; 800 home health facilities; 40 employer sites and 1,600 retail pharmacies. Selling additional solutions back into this client base is an important element of our future revenue growth. We are also focused on driving growth through market share expansion by strategically aligning with health care providers that have not yet selected a supplier and by displacing competitors in health care settings that are planning to replace their current supplier.

We expect to drive growth through new initiatives and services that reflect our ongoing ability to innovate and expand our reach into health care. Examples of these include our CareAware® health care device architecture and devices, Cerner HealtheSM employer services, Cerner ITWorksSM services, Cerner RevWorksSM services, and solutions on our

 

11


Table of Contents

Healthe Intent platform. Finally, we believe there is significant opportunity for growth outside of the United States, with many non-U.S. markets focused on health care information technology (HCIT) as part of their strategy to improve the quality and lower the cost of health care.

Beyond our strategy for driving revenue growth, we are also focused on earnings growth. Similar to our history of growing revenue, our net earnings have increased at compound annual rates of more than 20% over the most recent five- and ten-year periods. We expect to drive continued earnings growth through ongoing revenue growth coupled with margin expansion, which we expect to achieve through efficiencies in our implementation and operational processes and by leveraging R&D investments and controlling general and administrative expenses.

We are also focused on continuing to deliver strong levels of cash flow, which we expect to do by continuing to grow earnings and prudently managing capital expenditures.

Results Overview

The Company delivered strong levels of bookings, revenues, earnings and cash flows in the first quarter of 2012.

New business bookings, which reflects the value of executed contracts for software, hardware, professional services and managed services, was $652.3 million in the first quarter of 2012, which was an increase of 24% compared to $524.9 million in the first quarter of 2011. Revenues for the first quarter of 2012 increased 30% to $641.2 million compared to $491.7 million in the year-ago quarter. The year-over-year increase in revenue reflects ongoing demand related to “meaningful use” incentives that we believe are increasing the focus of health care providers on improving the efficiency and quality of health care through the use of information technology and related services.

First quarter 2012 net earnings increased 37% to $88.7 million compared to $64.6 million in the first quarter of 2011. Diluted earnings per share increased 38% to $0.51 compared to $0.37 in the first quarter of 2011. First quarter 2012 and 2011 net earnings and diluted earnings per share reflect the impact of stock-based compensation expense. The effect of these expenses reduced the first quarter 2012 net earnings and diluted earnings per share by $5.5 million and $0.03, respectively, and first quarter 2011 net earnings and diluted earnings per share by $4.6 million and $0.03, respectively.

The growth in net earnings and diluted earnings per share was driven primarily by strong revenue growth and continued progress with our margin expansion initiatives, particularly leveraging R&D investments and controlling selling, general and administrative expenses. Our first quarter 2012 operating margin was 19.9%, which is 80 basis points higher than the year-ago quarter.

We had strong cash collections of receivables of $683.2 million in the first quarter of 2012 compared to $531.1 million in the first quarter of 2011. Days sales outstanding was 76 days in the first quarter of 2012 compared to 83 days in the fourth quarter of 2011 and 87 days in the first quarter of 2011. Operating cash flows for the first quarter of 2012 were strong at $162.7 million compared to $126.5 million in the first quarter of 2011.

 

12


Table of Contents

Results of Operations

Three Months Ended March 31, 2012 Compared to Three Months Ended April 2, 2011

The following table presents a summary of the operating information for the first quarters of 2012 and 2011:

 

 

 

 

 

(In thousands)

  2012     % of
Revenue
     2011     % of
Revenue
    % Change    
 

 

 

 

Revenues

          

System sales

    $         225,820        35%       $         140,379        29%        61%    

Support and maintenance

    145,754        23%         131,827        27%        11%    

Services

    258,150        40%         209,167        42%        23%    

Reimbursed travel

    11,488        2%         10,291        2%        12%    
 

 

 

 

Total revenues

    641,212        100%         491,664        100%        30%    

Costs of revenue

          

Costs of revenue

    158,008        25%         90,680        18%        74%    
 

 

 

 

Total margin

    483,204        75%         400,984        82%        21%    

Operating expenses

          

Sales and client service

    245,074        38%         201,348        41%        22%    

Software development

    71,145        11%         71,144        15%        -        

General and administrative

    39,546        6%         34,793        7%        14%    
 

 

 

 

Total operating expenses

    355,765        55%         307,285        63%        16%    
 

 

 

 

Total costs and expenses

    513,773        80%         397,965        81%        29%    
 

 

 

 

Operating earnings

    127,439        20%         93,699        19%        36%    

Interest income, net

    2,619           1,976       

Other income, net

    5           35       

Income taxes

    (41,355        (31,154    
 

 

 

 

Net earnings

    $ 88,708         $ 64,556          37%    
 

 

 

 

Revenues & Backlog

Revenues increased 30% to $641.2 million for the first quarter of 2012 from $491.7 million for the same period in 2011.

 

 

 

System sales, which include revenues from the sale of licensed software, software as a service, technology resale (hardware, devices, and sublicensed software), deployment period licensed software upgrade rights, installation fees, transaction processing and subscriptions, increased 61% to $225.8 million for the first quarter of 2012 from $140.4 million for the same period in 2011. The increase in system sales was driven by a very strong increase in technology resale and strong increases in software, software as a service and subscriptions.

 

 

 

Support and maintenance revenues increased 11% to $145.8 million during the first quarter of 2012 from $131.8 million during the same period in 2011. This increase was attributable to continued success at selling Cerner Millennium applications and implementing them at client sites. We expect support and maintenance revenues will continue to grow as the base of installed Cerner Millennium systems grows.

 

 

 

Services revenue, which includes professional services, excluding installation, and managed services, increased 23% to $258.2 million from $209.2 million for the same period in 2011. This increase was driven by growth in CernerWorksSM managed services as a result of continued demand for our hosting services and an increase in professional services due to increased implementation activities and growth in Cerner ITWorks services and an increase in other consulting services.

Contract backlog, which reflects new business bookings that have not yet been recognized as revenue, increased 25% in the first quarter of 2012 compared to the same period in 2011. This increase was driven by growth in new business bookings during the past four quarters, including continued strong levels of managed services and Cerner ITWorks services bookings that typically have longer contract terms. A summary of our total backlog follows:

 

13


Table of Contents
KISHORE KUNAL KISHORE KUNAL
  

 

 

 

(In thousands)

   March 31, 2012     April 2, 2011    
  

 

 

 

Contract backlog

     $ 5,569,764      $ 4,460,603     

Support and maintenance backlog

     704,243        665,734     
  

 

 

 

Total backlog

     $ 6,274,007      $ 5,126,337     
  

 

 

 

Costs of Revenue

Cost of revenues was 25% of total revenues in the first quarter of 2012, compared to 18% in the same period of 2011. The higher cost of revenues as a percent of revenue was driven by a higher mix of technology resale, which carries a higher cost of revenue, and a slightly higher level of third party consulting costs. Cost of revenues includes the cost of reimbursed travel expense, sales commissions, third party consulting services and subscription content and computer hardware, devices and sublicensed software purchased from manufacturers for delivery to clients. It also includes the cost of hardware maintenance and sublicensed software support subcontracted to the manufacturers. Such costs, as a percent of revenues, typically have varied as the mix of revenue (software, hardware, devices, maintenance, support, services and reimbursed travel) carrying different margin rates changes from period to period. Cost of revenues does not include the costs of our client service personnel who are responsible for delivering our service offerings. Such costs are included in sales and client service expense.

Operating Expenses

Total operating expenses increased 16% to $355.8 million in the first quarter of 2012, compared with $307.3 million for the same period in 2011.

 

 

 

Sales and client service expenses as a percent of total revenues were 38% in the first quarter of 2012, compared to 41% in the same period of 2011. These expenses increased 22% to $245.1 million in the first quarter of 2012, from $201.3 million in the same period of 2011. Sales and client service expenses include salaries of sales and client service personnel, depreciation and other expenses associated with our CernerWorks managed service business, communications expenses, unreimbursed travel expenses, expense for share-based payments, sales and marketing salaries and trade show and advertising costs. The decrease as a percent of revenue reflects ongoing efficiencies in our implementation and operational processes.

 

 

 

Software development expenses as a percent of revenue were 11% in the first quarter of 2012, compared to 15% in the same period of 2011. Expenditures for software development reflect ongoing development and enhancement of the Cerner Millennium platform, including investments in the next evolution of Cerner Millennium, Millennium+™, which leverages the cloud and enables greater mobility. The reduction as a percentage of revenue reflects our ongoing efforts to control spending relative to revenue growth. Because of the strong platform we have built, we are able to continue advancing our solutions and investing in new solutions without large increases in spending. A summary of our total software development expense in the first quarters of 2012 and 2011 is as follows:

0000$000,000,0000 0000$000,000,0000
     Three Months Ended  

(In thousands)

   2012     2011  
  

 

 

 

Software development costs

     $ 74,836      $ 72,552      

Capitalized software costs

     (22,651     (20,171)     

Capitalized costs related to share-based payments

     (429     (295)     

Amortization of capitalized software costs

     19,389        19,058      
  

 

 

 

Total software development expense

     $ 71,145      $ 71,144      
  

 

 

 

 

 

 

General and administrative expenses as a percent of total revenues were 6% in the first quarter of 2012, compared to 7% in the same period of 2011. These expenses increased 14% to $39.5 million in the first quarter of 2012, from $34.8 million for the same period in 2011. General and administrative expenses include salaries for corporate, financial and administrative staffs, utilities, communications expenses, professional fees, transaction gains or losses on foreign currency and expense for share based payments. The increase in general and administrative expenses was primarily driven by an increase in corporate personnel costs, as we have increased such personnel to support our overall revenue growth.

 

14


Table of Contents

Non-Operating Items

 

 

 

Net interest income was $2.6 million in the first quarter of 2012, compared to net interest income of $2.0 million in the first quarter of 2011. Interest income increased to $4.1 million in the first quarter of 2012 from $3.5 million for the same period in 2011 due primarily to growth in investments. Interest expense was $1.5 million in the first quarters of 2012 and 2011.

 

 

 

Our effective tax rate was 31.8% for the first quarter of 2012 and 32.6% for the first quarter of 2011. This decrease was primarily due to an increase in net favorable discrete items recorded in 2012 relative to 2011, partially offset by the expiration of the research and development tax credit on December 31, 2011. Refer to Note (4) of the notes to the condensed consolidated financial statements for further information regarding our effective tax rate.

Operations by Segment

We have two operating segments, Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States. The Global segment includes revenue contributions and expenditures linked to business activity in Argentina, Aruba, Australia, Austria, Canada, Cayman Islands, Chile, China (Hong Kong), Egypt, England, France, Germany, Guam, India, Ireland, Italy, Japan, Malaysia, Morocco, Puerto Rico, Qatar, Saudi Arabia, Singapore, Spain, Sweden, Switzerland and the United Arab Emirates.

The following table presents a summary of the operating information for the first quarters of 2012 and 2011:

 

  

 

 

(In thousands)

   2012     % of Revenue   2011     % of Revenue   % Change  
  

 

 

Domestic Segment

          

Revenues

     $ 554,274      100%   $ 420,990      100%   32%

Costs of revenue

     134,303        24%     77,925        19%   72%

Operating expenses

     120,438        22%     105,349        25%   14%
  

 

 

Total costs and expenses

     254,741        46%     183,274        44%   39%
  

 

 

Domestic operating earnings

     299,533        54%     237,716        56%   26%
  

 

 

Global Segment

          

Revenues

     86,938      100%     70,674      100%   23%

Costs of revenue

     23,705        27%     12,755        18%   86%

Operating expenses

     32,751        38%     29,099        41%   13%
  

 

 

Total costs and expenses

     56,456        65%     41,854        59%   35%
  

 

 

Global operating earnings

     30,482        35%     28,820        41%   6%
  

 

 

Other, net

     (202,576       (172,837     17%
  

 

 

Consolidated operating earnings

     $           127,439        $           93,699        36%
  

 

 

Domestic Segment

 

 

Revenues increased 32% to $554.3 million in the first quarter of 2012 from $421.0 million in the same period in 2011. This increase was driven by growth across all business models, with particular strength in technology resale and professional services.

 

 

 

Cost of revenues was 24% of revenues in the first quarter of 2012, compared to 19% of revenues in the same period in 2011. The higher cost of revenues as a percent of revenue was primarily driven by a higher mix of technology resale, which carries a higher cost of revenue, and a slightly higher level of third party consulting costs.

 

 

 

Operating expenses increased 14% to $120.4 million in the first quarter of 2012, from $105.3 million in the same period in 2011, due primarily to growth in managed services and professional services expenses.

 

15


Table of Contents

Global Segment

 

 

 

Revenues increased 23% to $86.9 million in the first quarter of 2012 from $70.7 million in the same period in 2011. This increase was driven by strong growth in technology resale.

 

 

 

Cost of revenues was 27% of revenues in the first quarter of 2012, compared with 18% in the same period of 2011. The higher cost of revenues as a percent of revenue was primarily driven by a higher mix of technology resale, which carries a higher cost of revenue.

 

 

 

Operating expenses increased 13% to $32.8 million for the first quarter of 2012, from $29.1 million in the same period in 2011, primarily due to an increase in personnel-related expense.

Other, net

Operating results not attributed to an operating segment include expenses, such as centralized professional services costs, software development, marketing, general and administrative, stock-based compensation, depreciation, and amortization. These expenses increased 17% to $202.6 million in the first quarter of 2012 from $172.8 million in the same period in 2011. This increase was primarily due to growth in corporate and development personnel costs and other non-personnel costs.

Liquidity and Capital Resources

Our liquidity is influenced by many factors, including the amount and timing of our revenues, our cash collections from our clients and the amount we invest in software development, acquisitions and capital expenditures.

Our principal sources of liquidity are our cash, cash equivalents, which consist of money market funds, time deposits and bonds with original maturities of less than 90 days, and short-term investments. At March 31, 2012, we had cash and cash equivalents of $281.2 million and short-term investments of $612.6 million, as compared to cash and cash equivalents of $243.1 million and short-term investments of $531.6 million at December 31, 2011.

Approximately 16% of our aggregate cash, cash equivalents and short-term investments at March 31, 2012, were held outside of the United States. As part of our business strategy, we plan to indefinitely reinvest the earnings of our foreign operations; however, should the earnings of our foreign operations be repatriated, we would accrue and pay tax on such earnings, which may be material.

Additionally, we maintain a $100.0 million, multi-year revolving credit facility, which expires in February 2017. The facility provides an unsecured revolving line of credit for working capital purposes, along with a letter of credit facility. As of March 31, 2012, we had no outstanding borrowings under this agreement; however, we have $17.6 million of outstanding letters of credit, which reduced our available borrowing capacity to $82.4 million.

We believe that our present cash position, together with cash generated from operations, short-term investments and, if necessary, our available lines of credit, will be sufficient to meet anticipated cash requirements during 2012.

The following table summarizes our cash flows in the first three months of 2012 and 2011:

 

KISHORE KUNAL KISHORE KUNAL
     Three Months Ended  

(In thousands)

   2012     2011  
  

 

 

 

Cash flows from operating activities

     $ 162,708      $ 126,501      

Cash flows from investing activities

     (152,443     (190,265)     

Cash flows from financing activities

     26,311        31,145      

Effect of exchange rate changes on cash

     1,476        2,675      
  

 

 

 

Total change in cash and cash equivalents

     38,052        (29,944)     

Cash and cash equivalents at beginning of period

     243,146        214,511      
  

 

 

 

Cash and cash equivalents at end of period

     $ 281,198      $ 184,567      
  

 

 

 

Free cash flow (non-GAAP)

     $ 113,265      $ 84,663      
  

 

 

 

 

16


Table of Contents

Cash from Operating Activities

 

KISHORE KUNAL KISHORE KUNAL
     Three Months Ended  

(In thousands)

   2012     2011  
  

 

 

 

Cash collections from clients

     $ 683,245      $ 531,089      

Cash paid to employees and suppliers and other

     (459,297     (389,194)     

Cash paid for interest

     (3     (348)     

Cash paid for taxes, net of refund

     (61,237     (15,046)     
  

 

 

 

Total cash from operations

     $ 162,708      $ 126,501      
  

 

 

 

Cash flow from operations increased in the first three months of 2012 as compared to the same period of 2011 due primarily to the increase in cash impacting earnings, along with cash provided by working capital changes. During the first three months of 2012 and 2011, we received total client cash collections of $683.2 million and $531.1 million, respectively, of which 2% and 3%, respectively, were received from third party client financing arrangements and non-recourse payment assignments. Days sales outstanding was 76 days in the first quarter of 2012, 83 days in the fourth quarter of 2011 and 87 days in the first quarter of 2011. Revenues provided under support and maintenance agreements represent recurring cash flows. Support and maintenance revenues increased 11% in the first three months of 2012 compared to the first three months of 2011. We expect these revenues to continue to grow as the base of installed Cerner Millennium systems grows.

Cash from Investing Activities

 

KISHORE KUNAL KISHORE KUNAL
     Three Months Ended  

(In thousands)

   2012     2011  
  

 

 

 

Capital purchases

     $ (26,363   $ (21,372)     

Capitalized software development costs

     (23,080     (20,466)     

Purchases of investments, net of maturities

     (100,101     (145,199)     

Other, net

     (2,899     (3,228)     
  

 

 

 

Total cash flows from investing activities

     $ (152,443   $ (190,265)     
  

 

 

 

Cash flows from investing activities consist primarily of capital spending and our short-term investment activities. Capital spending consists of capitalized equipment purchases primarily to support growth in our CernerWorks managed services business, building and improvement purchases to support our facilities requirements and capitalized spending to support our ongoing software development initiatives. Capital spending throughout 2012 is expected to increase from our 2011 levels; however, we still expect strong levels of free cash flow.

Short-term investment activity consists of the investment of cash generated by our business in excess of what is necessary to fund operations. We expect to continue such short-term investment activity throughout 2012, as we expect strong levels of free cash flow.

Cash from Financing Activities

 

KISHORE KUNAL KISHORE KUNAL
     Three Months Ended  

(In thousands)

   2012     2011  
  

 

 

 

Repayment of long-term debt

     $ (970   $ (114)     

Cash from option exercises (including excess tax benefits)

     27,281        32,039      

Other, net

     -        (780)     
  

 

 

 

Total cash flows from financing activities

     $ 26,311      $ 31,145      
  

 

 

 

Cash inflows from stock option exercises are dependent on a number of factors, including the price of our common stock, grant activity under our stock option and equity plans, and overall market volatility. We expect cash inflows from stock option exercises to continue throughout 2012 based on the number of exercisable options at March 31, 2012 and our current stock price.

 

17


Table of Contents

Free Cash Flow.

 

00,000,000 00,000,000
     Three Months Ended  

(In thousands)

   2012     2011  
  

 

 

 

Cash flows from operating activities (GAAP)

    $ 162,708      $   126,501      

Capital purchases

     (26,363     (21,372)     

Capitalized software development costs

     (23,080     (20,466)     
  

 

 

 

Free cash flow (non-GAAP)

    $ 113,265      $ 84,663      
  

 

 

 

Free cash flow increased $28.6 million in the first three months of 2012 as compared to the same period in 2011, which we believe reflects continued strengthening of our earnings quality. Free cash flow is a non-GAAP financial measure used by management along with GAAP results to analyze our earnings quality and overall cash generation of the business. The presentation of free cash flow is not meant to be considered in isolation, nor as a substitute for, or superior to, GAAP results and investors should be aware that non-GAAP measures have inherent limitations and should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP. Free cash flow may also be different from similar non-GAAP financial measures used by other companies and may not be comparable to similarly titled captions of other companies due to potential inconsistencies in the method of calculation. We believe free cash flow is important to enable investors to better understand and evaluate our ongoing operating results and allows for greater transparency in the review of our overall financial, operational and economic performance because free cash flow takes into account the capital expenditures necessary to operate our business.

 

18


Table of Contents

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

No material changes.

 

Item 4.

Controls and Procedures

 

 

a)

Evaluation of disclosure controls and procedures. The Company’s Chief Executive Officer (CEO) and Chief Financial Officer (CFO) have evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in the Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this quarterly report on Form 10-Q (the Evaluation Date). They have concluded that, as of the Evaluation Date, these disclosure controls and procedures were effective to ensure that material information relating to the Company and its consolidated subsidiaries would be made known to them by others within those entities and would be disclosed on a timely basis. The CEO and CFO have concluded that the Company’s disclosure controls and procedures are designed, and are effective, to give reasonable assurance that the information required to be disclosed by the Company in reports that it files under the Exchange Act is recorded, processed, summarized and reported within the time period specified in the rules and forms of the SEC. They have also concluded that the Company’s disclosure controls and procedures are effective to ensure that information required to be disclosed in the reports that are filed or submitted under the Exchange Act are accumulated and communicated to the Company’s management to allow timely decisions regarding required disclosure.

 

 

b)

There were no changes in the Company’s internal controls over financial reporting during the three months ended March 31, 2012 that have materially affected, or are reasonably likely to materially affect, the Company’s internal controls over financial reporting.

 

 

c)

The Company’s management, including its CEO and CFO, has concluded that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives and are effective at that reasonable assurance level. However, the Company’s management can provide no assurance that our disclosure controls and procedures or our internal control over financial reporting can prevent all errors and all fraud under all circumstances. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been or will be detected. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

 

19


Table of Contents

Part II. Other Information

 

Item 6.

Exhibits

 

(a)

Exhibits

10.1

  

2012 Executive Performance Agreement Pursuant to Cerner’s Performance-Based Compensation Plan

10.2

  

Amended and Restated Credit Agreement, dated February 10, 2012, incorporated by reference to Exhibit 99.1 to Form 8-K filed February 13, 2012.

31.1

  

Certification of Neal L. Patterson pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

  

Certification of Marc G. Naughton pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

  

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2

  

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS+

  

XBRL Instance Document

101.SCH+

  

XBRL Taxonomy Extension Schema Document

101.CAL+

  

XBRL Taxonomy Extension Calculation Linkbase Document

101.LAB+

  

XBRL Taxonomy Extension Labels Linkbase Document

101.PRE+

  

XBRL Taxonomy Extension Presentation Linkbase Document

101.DEF+

  

XBRL Taxonomy Extension Definition Linkbase Document

+ XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, is not deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.

 

 

20


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

  

CERNER CORPORATION

  

Registrant

April 27, 2012  

  

By: /s/Marc G. Naughton    

Date

  

Marc G. Naughton

  

Executive Vice President and

  

Chief Financial Officer

  

(duly authorized officer and

  

principal financial officer)

XNAS:CERN Cerner Corp Quarterly Report 10-Q Filling

Cerner Corp XNAS:CERN Stock - Get Quarterly Report SEC Filing of Cerner Corp XNAS:CERN stocks, including company profile, shares outstanding, strategy, business segments, operations, officers, consolidated financial statements, financial notes and ownership information.

XNAS:CERN Cerner Corp Quarterly Report 10-Q Filing - 3/31/2012
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Title |  Date |  Company |  Symbol |  Interest |  Popularity

Previous: XNAS:CERN Cerner Corp Insider Activity 4 Filing - 9/7/2012  |  Next: XNAS:CERN Cerner Corp Quarterly Report 10-Q Filing - 6/30/2012